戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  of Ras or a dominant-negative form of MEK1 (mitogen-activated protein kinase kinase 1).
2 rrolo[3,4-c]carbazole-12-p ropanenitrile and mitogen-activated protein kinase kinase 1 2-(2-amino-3-m
3           We further find that modulation of Mitogen Activated Protein Kinase Kinase-1/2 (MAP2K1/2, M
4 sed by pharmacologic and siRNA inhibitors of mitogen-activated protein kinase kinase 1/2 (MEK1/2) and
5 phynylthio)butadiene]-specific inhibitors of mitogen-activated protein kinase kinase 1/2 (MEK1/2) blo
6 ERK1/2), and the combination of SMI-4a and a mitogen-activated protein kinase kinase 1/2 (MEK1/2) inh
7 gonism of PGE2 release was achieved with the mitogen-activated protein kinase kinase 1/2 (MEK1/2) inh
8  between 7-hydroxystaurosporine (UCN-01) and mitogen-activated protein kinase kinase 1/2 (MEK1/2) inh
9 tion that 20S reduction has little effect on mitogen-activated protein kinase kinase 1/2 (MEK1/2) sig
10 , cardiac expression of phospho-Akt, phospho-mitogen-activated protein kinase kinase 1/2 and phospho-
11                Preclinical evaluation of the mitogen-activated protein kinase kinase 1/2 inhibitor se
12 anner, combined exposure to OSU-03012 with a mitogen-activated protein kinase kinase 1/2 inhibitor, p
13                   Both Ly294002 and U0126, a mitogen-activated protein kinase kinase 1/2 inhibitor, r
14 ess signaling pathways demonstrated that the mitogen-activated protein kinase kinase 1/2 pathway acti
15 by cytokines and suppressed by inhibition of mitogen-activated protein kinase kinase 1/2, whereas STE
16                                      The RAF-mitogen-activated protein kinase kinase 1/2-extracellula
17 nd degradation, and subsequent activation of mitogen-activated protein kinase kinase 1/2.
18 al-regulated kinases 1/2 phosphorylation was mitogen-activated protein kinase kinases 1/2 dependent b
19                                       Use of mitogen-activated protein kinase kinases 1/2 inhibitors
20  human embryonic kidney 293 cells, Raf-1 and mitogen-activated protein kinase kinase 1 activities in
21 osphatase, proteasomal, phospholipase C, and mitogen-activated protein kinase kinase 1 activities.
22 othecin by expression of constitutive active mitogen-activated protein kinase kinase 1, an upstream k
23 ion of BRCA1-induced ERK1/2 activation using mitogen-activated protein kinase kinase 1 and 2 (MEK1/2)
24 ed induction of E-selectin, whereas PD98059 (mitogen-activated protein kinase kinase 1 and 2 inhibito
25 nhibitor of the dual-specificity kinases MEK(mitogen-activated protein kinase kinase) -1 and MEK2 , i
26                     The C-terminal region of mitogen-activated protein kinase kinase-1 and 2 (MKK1 an
27                                Activation of mitogen-activated protein kinase kinases 1 and 2 (MEK1 a
28 that the hepatocyte growth factor activator, mitogen-activated protein kinase kinase 1, and phosphati
29   The expression of constitutively activated mitogen-activated protein kinase kinase 1 enhanced caspa
30 ant-negative mutant of the ERK1/2 activator, mitogen-activated protein kinase kinase 1, increased the
31             Chemical inhibition of PI-3K and mitogen-activated protein kinase kinase 1 inhibited E(2)
32 y, and the effects of LT were independent of mitogen-activated protein kinase kinase 1 inhibition.
33 ression of the alpha7 integrin or use of the mitogen-activated protein kinase kinase 1 inhibitor U012
34 , although disruption of this pathway by the mitogen-activated protein kinase kinase 1 inhibitor U012
35                                   PD98059, a mitogen-activated protein kinase kinase 1 inhibitor, als
36 ted and ddPCR confirmed somatic mutations in mitogen activated protein kinase kinase 1 (MAP2K1), the
37 lleles in Ras-like without CAAX 1 (RIT1) and mitogen-activated protein kinase kinase 1 (MAP2K1) and p
38 atment with PD98059, a specific inhibitor of mitogen-activated protein kinase kinase 1 (MAPKK1 (MEK1)
39 n has been linked to its ability to activate mitogen-activated protein kinase kinase 1 (MEK) and mito
40 nhibitor, PD58029, which is specific for the mitogen-activated protein kinase kinase 1 (MEK-1), also
41 constitutively active form of MEKK-1 but not mitogen-activated protein kinase kinase-1 (MEK-1) or TGF
42  Instead, fragmentation depends on cytosolic mitogen-activated protein kinase kinase 1 (MEK1 or MAPKK
43 ion of a constitutively active mutant of the mitogen-activated protein kinase kinase 1 (MEK1(E)), the
44                      Conversely, conditional mitogen-activated protein kinase kinase 1 (Mek1) activat
45  Overexpression of V1, V2, or GIT1 activated mitogen-activated protein kinase kinase 1 (MEK1) and ext
46 gulated kinase (ERK)1/2 and Akt and both the mitogen-activated protein kinase kinase 1 (MEK1) and pho
47 where it acts as a metalloprotease to cleave mitogen-activated protein kinase kinase 1 (MEK1) and pos
48 owever, the expression of a kinase-deficient mitogen-activated protein kinase kinase 1 (MEK1) did not
49       The response was blocked by a specific mitogen-activated protein kinase kinase 1 (MEK1) inhibit
50 AK-null cells, constitutively activated (CA) mitogen-activated protein kinase kinase 1 (MEK1) restore
51 us via a signaling pathway in which c-Raf-1, mitogen-activated protein kinase kinase 1 (MEK1), and th
52                 Using an activated allele of mitogen-activated protein kinase kinase 1 (MEK1), we sho
53 on of dominant-negative mutants of C-Raf1 or mitogen-activated protein kinase kinase 1 (MEK1).
54  this process requires the cytosolic protein mitogen-activated protein kinase kinase 1 (MEK1).
55          Previous studies have reported that mitogen-activated protein kinase kinase-1 (MEK1) and Cdc
56 Here, we demonstrate that acetylation of the mitogen-activated protein kinase kinase-1 (MEK1) stimula
57 sic pathway of apoptosis, independent of the mitogen-activated protein kinase kinase-1 (MEK1).
58          NF-kappaB-inducing kinase (NIK) and mitogen-activated protein kinase kinase-1 (MEKK-1) were
59 s article, we demonstrate that LPA activates mitogen-activated protein kinase kinase 1 (MEKK1) in a G
60 stimulation of N-Myc and the stress-mediated mitogen-activated-protein kinase kinase 1 (MEKK1) pathwa
61 airway smooth muscle proliferation, with the mitogen-activated protein kinase kinase 1/mitogen-activa
62 efine conditions for nuclear localization of mitogen-activated protein kinase kinase 1 (MKK1) by exam
63                      The activation of human mitogen-activated protein kinase kinase 1 (MKK1) is achi
64  Ectopic expression of constitutively active mitogen-activated protein kinase kinase 1 (MKK1) resulte
65 FR with AG1478 or small interfering RNA), or mitogen-activated protein kinase kinase 1 or 2 (MKK1/2 w
66 activating mutation in exon 2 of MEK1 (i.e., mitogen-activated protein kinase kinase 1 or MAP2K1) tha
67 ed by inhibiting HBx stimulation of N-Myc or mitogen-activated-protein kinase kinase 1 using dominant

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。